Global Metformin Hydrochloride Sales Market Report 2020

Metformin Hydrochloride is the raw material of finished product metformin hydrochloride drugs. That is the API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in the management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents.
For the API product, there are many manufacturers in India, China, and Europe, such as Wanbury, USV, Shouguang Fukang Pharmaceutical, Vistin Pharma, CR Double-Crane and Keyuan Pharmaceutical. Among them, Wanbury and USV are global leading manufacturers with capacity nearly 10000 MT relatively. Metformin hydrochloride has mainly two types, which include Metformin HCL and Metformin DC, etc. With medical effect of metformin hydrochloride, the downstream application industries will need more metformin hydrochloride products. So, metformin hydrochloride has a huge market potential in the future.

Market Analysis and Insights: Global Metformin Hydrochloride Market
The global Metformin Hydrochloride market size is projected to reach US$ 371.8 million by 2026, from US$ 269.6 million in 2020, at a CAGR of 5.5% during 2021-2026.

Global Metformin Hydrochloride Scope and Market Size
The global Metformin Hydrochloride market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Metformin Hydrochloride market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Metformin Hydrochloride market is segmented into
Metformin HCL
Metformin DC
Others

Segment by Application, the Metformin Hydrochloride market is segmented into
Metformin Hydrochloride Tablets
Metformin Hydrochloride Extended-Release Tablets
Others Form

The Metformin Hydrochloride market is analysed and market size information is provided by regions (countries). Segment by Application, the Metformin Hydrochloride market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape

and Metformin Hydrochloride Market Share Analysis
Metformin Hydrochloride market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Metformin Hydrochloride business, the date to enter into the Metformin Hydrochloride market, Metformin Hydrochloride product introduction, recent developments, etc.

The major vendors covered:
Wanbury
USV
Shouguang Fukang Pharmaceutical
Vistin Pharma
CR Double-Crane
Keyuan Pharmaceutical
Farmhispania Group
Harman Finochem
Shijiazhuang Polee Pharmaceutical
Aarti Drugs
Exemed Pharmaceuticals